[1]赖斌,许兆光,何发胜,等.影响富血小板血浆修复膝骨关节炎的相关因素研究进展[J].中国中医骨伤科杂志,2024,32(12):92-96.[doi:10.20085/j.cnki.issn1005-0205.241218 ]
 LAI Bin,XU Zhaoguang,HE Fasheng,et al.Research Progress on Influencing Factors of Platelet Rich Plasma in the Treatment of Knee Osteoarthritis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2024,32(12):92-96.[doi:10.20085/j.cnki.issn1005-0205.241218 ]
点击复制

影响富血小板血浆修复膝骨关节炎的相关因素研究进展()
分享到:

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第32卷
期数:
2024年12期
页码:
92-96
栏目:
文献综述
出版日期:
2024-12-15

文章信息/Info

Title:
Research Progress on Influencing Factors of Platelet Rich Plasma in the Treatment of Knee Osteoarthritis
文章编号:
1005-0205(2024)12-0092-05
作者:
赖斌1许兆光1何发胜1徐乐勤1△
1福建中医药大学附属厦门中医院(福建 厦门,361009)
Author(s):
LAI Bin1XU Zhaoguang1HE Fasheng1XU Leqin1△
1Xiamen Hospital of Traditional Chinese Medicine,Fujian University of Traditional Chinese Medicine,Xiamen 361009,Fujian China.
关键词:
膝骨关节炎 富血小板血浆 关节腔内注射 血小板浓度 标准化 细胞因子
Keywords:
knee osteoarthritis platelet rich plasma intraarticular injection platelet concentration standardization cell factor
分类号:
R684.3
DOI:
10.20085/j.cnki.issn1005-0205.241218
文献标志码:
A
摘要:
关节腔内注射富血小板血浆(PRP)作为膝骨关节炎(KOA)保守治疗的一种创新方案,正日益受到关注。鉴于富血小板血浆富含多种生长因子,具有促进软骨修复的能力,在骨与软骨退行性疾病的治疗领域得到了广泛应用。然而在临床实践中,富血小板血浆的制备流程、储存条件及注射技术等环节方法多样化,这些差异直接影响了其治疗效果。因此,本综述旨在深入探讨富血小板血浆制剂的组成成分、保存策略及具体使用方法等因素对治疗膝骨关节炎的疗效影响,以期为临床实践中富血小板血浆的规范化应用提供科学依据和参考。
Abstract:
Intraarticular injection of platelet rich plasma(PRP)was one of the new conservative treatments for knee osteoarthritis(KOA).PRP was considered to have the effect of repairing cartilage because it contains a large amount of growth factors.Nowadays,it was widely used in the treatment of degenerative diseases of bone and cartilage.However,there were various methods for preparing,storing,and injecting PRP in clinically.Different methods lead to certain differences in clinical efficacy.Therefore,this review analyzed the factors influencing the efficacy of PRP in the treatment of KOA from the aspects of composition,storage and use,in order to provide reference for the clinical application of PRP.

参考文献/References:

[1] 朱治龙,黄国鑫,艾金伟,等.全球膝关节骨性关节炎发病率和患病率分析与趋势预测[J].湖北医药学院学报,2023,42(6):647-654.
[2] 叶恒力,贾朝旭,傅繁誉,等.国内膝骨关节炎指南和共识的质量评价[J].中医正骨,2021,33(6):36-41.
[3] CHRISTIN I S,MUTHUKANNAN H,KARUPPANAN S,et al.Clinical use of plasma protein from platelet in degenerative joint disease:a prospective study[J].J Orthop Case Rep,2022,12(11):105-109.
[4] SDEEK M,SABRY D,EL-SDEEK H,et al.Intra-articular injection of platelet rich plasma versus hyaluronic acid for moderate knee osteoarthritis:a prospective,double-blind randomized controlled trial on 189 patients with follow-up for three years[J].Acta Orthop Belg,2021,87(4):729-734.
[5] 胡坚伟,徐凌志.富血小板血浆关节腔注射治疗膝骨关节炎的临床疗效[J].吉林医学,2023,44(6):1555-1557.
[6] 张珑,赵方,丛宝华,等.自体富血小板血浆治疗老年膝关节骨性关节炎的临床疗效研究[J].中国实用医药,2024,19(6):52-55.
[7] KOLASINSKI S L,NEOGI T,HOCHBERG M C,et al.2019 American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand,hip,and knee[J].Arthritis Rheumatol,2020,72(2):220-233.
[8] BANNURU R R,OSANI M C,VAYSBROT E E,et al.OARSI guidelines for the non-surgical management of knee,hip,and polyarticular osteoarthritis[J].Osteoarthritis Cartilage,2019,27(11):1578-1589.
[9] NGUYEN P A,PHAM T.Effects of platelet-rich plasma on human gingival fibroblast proliferation and migration in vitro[J].J Appl Oral Sci,2018,26:e20180077.
[10] EVERTS P A,VAN ERP A,DESIMONE A,et al.Platelet rich plasma in orthopedic surgical medicine[J].Platelets,2021,32(2):163-174.
[11] EVERTS P,ONISHI K,JAYARAM P,et al.Platelet-rich plasma:new performance understandings and therapeutic considerations in 2020[J].Int J Mol Sci,2020,21(20):7794.
[12] 房昕,郭金铭,刘品端.不同浓度富血小板血浆修复兔膝骨关节炎软骨缺损的比较[J].中国组织工程研究,2021,25(35):5588-5593.
[13] 孙云明,张团结,卢锦.不同血小板浓度的自体PRP治疗膝关节骨性关节炎的效果对比[J].当代医药论丛,2020,18(21):27-28.
[14] 邬良平,杜中华,马小松,等.不同浓度富血小板血浆治疗早中期膝骨关节炎的临床疗效研究[J].中国医学工程,2021,29(1):9-14.
[15] 王一帆,李小峰,罗道明,等.不同浓度富血小板血浆治疗膝关节骨性关节炎临床疗效研究[J].陕西医学杂志,2018,47(9):1113-1118.
[16] 殷文靖,徐正良,盛加根,等.去白细胞和富白细胞富血小板血浆对软骨细胞增殖迁移的作用[J].中华关节外科杂志(电子版),2016,10(6):618-623.
[17] 潘磊,蔡东成,吴刚.乏白细胞富血小板血浆与富白细胞富血小板血浆对兔牙髓间充质干细胞增殖和成骨分化的影响[J].山东医药,2018,58(36):50-53.
[18] MARTINO A D,BOFFA A,ANDRIOLO L,et al.Leukocyte-rich versus leukocyte-poor platelet-rich plasma for the treatment of knee osteoarthritis:a double-blind randomized trial[J].Am J Sports Med,2022,50(3):609-617.
[19] ABBAS A,DU J T,DHOTAR H S.The effect of leukocyte concentration on platelet-rich plasma injections for knee osteoarthritis:a network meta-analysis[J].J Bone Joint Surg Am,2022,104(6):559-570.
[20] KIM J H,PARK Y B,HA C W,et al.Adverse reactions and clinical outcomes for leukocyte-poor versus leukocyte-rich platelet-rich plasma in knee osteoarthritis:a systematic review and meta-analysis[J].Orthop J Sports Med,2021,9(6):941617004.
[21] MAGALON J,VELIER M,FRANCOIS P,et al.Comment on “responders to platelet-rich plasma in osteoarthritis:a technical analysis”[J].Biomed Res Int,2017:8620257.
[22] DI NICOLA V.Degenerative osteoarthritis:a reversible chronic disease[J].Regen Ther,2020,15:149-160.
[23] TISCHER T,BODE G,BUHS M,et al.Platelet-rich plasma(PRP)as therapy for cartilage,tendon and muscle damage-German working group position statement[J].J Exp Orthop,2020,7(1):64.
[24] COLLINS T,ALEXANDER D,BARKATALI B.Platelet-rich plasma:a narrative review[J].EFORT Open Rev,2021,6(4):225-235.
[25] KIKUCHI N,YOSHIOKA T,TANIGUCHI Y,et al.Optimization of leukocyte-poor platelet-rich plasma preparation:a validation study of leukocyte-poor platelet-rich plasma obtained using different preparer,storage,and activation methods[J].J Exp Orthop,2019,6(1):24.
[26] 杨丽娟,胡燕,吴雅娟,等.富血小板血浆采集制备及质量控制的回顾性分析[J].中国输血杂志,2023,36(10):946-948.
[27] 罗开云,王淑君,毛平平,等.不同保存方式对PRP相关生长因子影响的研究[J].临床输血与检验,2022,24(1):70-73.
[28] 武文,马红霞,黄象艳.不同储存条件对单采富血小板血浆关键生长因子含量影响的实验研究[J].中国输血杂志,2023,36(8):655-659.
[29] 蔺锡桐,刘加秀,张树超.富血小板血浆-80 ℃深低温短期保存后细胞因子的变化[J].精准医学杂志,2024,39(3):232-235.
[30] 许育兵,刘广亚,朱展鸿,等.超声引导下富血小板血浆注射对军事训练膝关节损伤的疗效分析[J].西北国防医学杂志,2018,39(8):509-513.
[31] HUGLE T,GEURTS J.What drives osteoarthritis-synovial versus subchondral bone pathology[J].Rheumatology(Oxford),2017,56(9):1461-1471.
[32] STEWART H L,KAWCAK C E.The importance of subchondral bone in the pathophysiology of osteoarthritis[J].Front Vet Sci,2018,5:178.
[33] 苏柯,白玉明,王军,等.关节内联合松质骨内注射富血小板血浆治疗膝骨关节炎的临床观察[J].中华关节外科杂志(电子版),2017,11(5):471-476.
[34] MEHEUX C J,MCCULLOCH P C,LINTNER D M,et al.Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis:a systematic review[J].Arthroscopy,2016,32(3):495-505.
[35] MONCKEBERG J E,RAFOLS C,APABLAZA F,et al.Intra-articular administration of peripheral blood stem cells with platelet-rich plasma regenerated articular cartilage and improved clinical outcomes for knee chondral lesions[J].Knee,2019,26(4):824-831.
[36] MANCO A,GODERECCI R,RUGHETTI A,et al.Microfracture versus microfracture and platelet-rich plasma:arthroscopic treatment of knee chondral lesions.A two-year follow-up study[J].Joints,2016,4(3):142-147.
[37] BARMAN A,BANDYOPADHYAY D,MOHAKUD S,et al.Comparison of clinical outcome,cartilage turnover,and inflammatory activity following either intra-articular or a combination of intra-articular with intra-osseous platelet-rich plasma injections in osteoarthritis knee:a randomized,clinical trial[J].Injury,2023,54(2):728-737.
[38] BELLIDO M,LUGO L,ROMAN-BLAS J A,et al.Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis[J].Osteoarthritis Cartilage,2011,19(10):1228-1236.

备注/Memo

备注/Memo:
基金项目:厦门市医疗卫生指导性项目(3502Z20224ZD1161)
厦门市自然科学基金项目联合项目(3502Z20227367)
福建省第四批老中医药专家学术经验继承项目
厦门市第六批优秀中青年中医后备人才项目
通信作者 E-mail:xuleqin@163.com
更新日期/Last Update: 2024-12-05